Biglycan Antikörper (C-Term)
(1 reference)-
- Target Alle Biglycan (BGN) Antikörper anzeigen
- Biglycan (BGN)
-
Bindungsspezifität
- C-Term
-
Reaktivität
- Human
-
Wirt
- Ziege
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser Biglycan Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA
- Verwendungszweck
- Goat polyclonal antibody raised against synthetic peptide of BGN.
- Sequenz
- C-DRLAIQFGNY KK
- Kreuzreaktivität
- Hund, Human, Maus, Ratte
- Immunogen
- A synthetic peptide corresponding to C-terminus of human BGN.
- Top Product
- Discover our top product BGN Primärantikörper
-
anti-Biglycan (BGN) (AA 1-368) antibody
BGN Reaktivität: Human WB, ELISA, IP, IHC (p) Wirt: Maus Monoclonal 4E1-1G7 unconjugated
anti-Biglycan (BGN) (AA 230-366) antibodyBGN Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Biglycan (BGN) (AA 53-166) antibodyBGN Reaktivität: Maus WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Biglycan (BGN) (C-Term) antibodyVerified BGN Reaktivität: Human, Maus ELISA, IF Wirt: Ziege Polyclonal unconjugated
anti-Biglycan (BGN) (AA 101-200) antibodyBGN Reaktivität: Human, Ratte, Maus, Kaninchen WB, ELISA, FACS, IHC (p), IF (cc), IF (p), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-Biglycan (BGN) (AA 148-176) antibodyBGN Reaktivität: Human WB, FACS, IHC (p) Wirt: Kaninchen Polyclonal RB19735 unconjugated
anti-Biglycan (BGN) (AA 38-300) antibodyBGN Reaktivität: Human IHC, ELISA, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Biglycan (BGN) antibodyBGN Reaktivität: Human, Ratte, Maus WB, IHC, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Biglycan (BGN) (AA 1-368) antibodyBGN Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Biglycan (BGN) antibodyBGN Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
-
ELISA (1:8000)
Western Blot (0.1-0.3 μg/mL)
The optimal working dilution should be determined by the end user. - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.5 mg/mL
- Buffer
- In Tris saline, pH 7.3 (0.5 % BSA, 0.02 % sodium azide)
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
-
Store at -20°C.
Aliquot to avoid repeated freezing and thawing.
-
-
: "Smad4/DPC4-dependent regulation of biglycan gene expression by transforming growth factor-beta in pancreatic tumor cells." in: The Journal of biological chemistry, Vol. 277, Issue 39, pp. 36118-28, (2002) (PubMed).
-
: "Smad4/DPC4-dependent regulation of biglycan gene expression by transforming growth factor-beta in pancreatic tumor cells." in: The Journal of biological chemistry, Vol. 277, Issue 39, pp. 36118-28, (2002) (PubMed).
-
- Target
- Biglycan (BGN)
- Andere Bezeichnung
- Biglycan (BGN Produkte)
- Synonyme
- DSPG1 antikoerper, PG-S1 antikoerper, PGI antikoerper, SLRR1A antikoerper, BG antikoerper, BSPG1 antikoerper, bgn antikoerper, zgc:91989 antikoerper, dspg1 antikoerper, pg-s1 antikoerper, slrr1a antikoerper, xbgn antikoerper, BGN antikoerper, zgc:77123 antikoerper, DKFZp468I2427 antikoerper, biglycan antikoerper, biglycan L homeolog antikoerper, biglycan a antikoerper, biglycan S homeolog antikoerper, biglycan b antikoerper, BGN antikoerper, Bgn antikoerper, bgn.L antikoerper, bgna antikoerper, bgn.S antikoerper, bgn antikoerper, bgnb antikoerper
- Gen-ID
- 633
- Pathways
- Glycosaminoglycan Metabolic Process
-
